Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatment

Eitemau Tebyg

• Early responses of EGFR circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatment
  gan: Imamura, Fumio, et al.
  Cyhoeddwyd: (2016)
• Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patients
  gan: Kato, Kikuya, et al.
  Cyhoeddwyd: (2016)
• Transient appearance of circulating tumor DNA associated with de novo treatment
  gan: Kato, Kikuya, et al.
  Cyhoeddwyd: (2016)
• Quantitative identification of mutant alleles derived from lung cancer in plasma cell-free DNA via anomaly detection using deep sequencing data.
  gan: Yoji Kukita, et al.
  Cyhoeddwyd: (2013-01-01)
• Quantitative Identification of Mutant Alleles Derived from Lung Cancer in Plasma Cell-Free DNA via Anomaly Detection Using Deep Sequencing Data
  gan: Kukita, Yoji, et al.
  Cyhoeddwyd: (2013)